Angiotensin-converting enzyme 2: virus accomplice or host defender?

被引:0
|
作者
Wang Jiyan [1 ]
Chang Hongkai [1 ]
Qiao Yaya [1 ]
Sun Huanran [1 ]
Li Xichuan [6 ]
Yuan Shuofeng [10 ]
Zhang Shuai [17 ]
Shan Changliang [1 ]
机构
[1] State Key Laboratory of Emerging Infectious Diseases
[2] Carol Yu Centre for Infection  12. Department of Microbiology  13. Li Ka Shing Faculty of Medicine 
[3] School of Integrative Medicine
[4] Tianjin University of Traditional Chinese Medicine  19. Tianjin 301617
[5] State Key Laboratory of Medicinal Chemical Biology
[6] College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research  3. Nankai University  4. Tianjin 300350 
[7] Tianjin Key Laboratory of Animal and Plant Resistance
[8] College of Life Sciences  8. Tianjin Normal University  9. Tianjin 300387
关键词
ACE2; asymptomatic infection; COVID-19; metabolism; SARS-CoV-2;
D O I
暂无
中图分类号
R511 [病毒传染病];
学科分类号
100401 ;
摘要
Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to social disruptions, mainly because we know too little about SARS-CoV-2.Methods and Results: In this study, we integrated RNA sequencing results and found that SARS-CoV-2 infection alters aerobic glycolysis, the oxidative pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication are dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interestingly, although hosts with a high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, eventually resulting in a prolonged infection cycle or infection failure.Conclusion: Our findings preliminarily explain the reasons for the emergence of asymptomatic infections at an early stage, which will provide assistance for the development of detection methods for diagnosing COVID-19.
引用
收藏
相关论文
共 50 条
  • [21] Angiotensin-Converting Enzyme 2: The First Decade
    Clarke, Nicola E.
    Turner, Anthony J.
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2012, 2012
  • [22] Physiological roles of angiotensin-converting enzyme 2
    Danilczyk, U
    Eriksson, U
    Oudit, GY
    Penninger, JM
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (21) : 2714 - 2719
  • [23] Angiotensin-converting enzyme 2 and renal disease
    Williams, Vanessa R.
    Scholey, James W.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (01): : 35 - 41
  • [24] ASSAY FOR ANGIOTENSIN-CONVERTING ENZYME
    RUSSO, SF
    JOURNAL OF CHEMICAL EDUCATION, 1983, 60 (09) : 779 - 780
  • [25] The leech angiotensin-converting enzyme
    Laurent, V
    Stefano, GB
    Salzet, M
    TRENDS IN COMPARATIVE ENDOCRINOLOGY AND NEUROBIOLOGY: FROM MOLECULAR TO INTEGRATIVE BIOLOGY, 1998, 839 : 500 - 502
  • [26] Angiotensin-Converting Enzyme Inhibitors
    Izzo, Joseph L., Jr.
    Weir, Matthew R.
    JOURNAL OF CLINICAL HYPERTENSION, 2011, 13 (09): : 667 - 675
  • [27] ANGIOTENSIN-CONVERTING ENZYME AND SARCOIDOSIS
    不详
    SOUTH AFRICAN MEDICAL JOURNAL, 1980, 58 (07): : 267 - 267
  • [28] ANGIOTENSIN-CONVERTING ENZYME AND NEUROSARCOIDOSIS
    AHMAD, S
    CHEST, 1991, 99 (04) : 1054 - 1054
  • [29] ASSAY FOR ANGIOTENSIN-CONVERTING ENZYME
    RUSSO, SF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (APR): : 109 - 109
  • [30] ANGIOTENSIN-CONVERTING ENZYME IN SARCOIDOSIS
    ROMER, FK
    ACTA MEDICA SCANDINAVICA, 1979, 206 (1-2): : 27 - 30